| Control group# | Treatment group¶ | |||||
| Visit 0 | Visit 6 | p-value | Visit 0 | Visit 6 | p-value | |
| BMI kg·m−2 | 37.29±1.07 | 36.85±1.06 | ns | 39.88±1.85 | 34.58±1.74 | <0.001*** |
| ACQ score | 2.91±0.25 | 2.90±0.16 | ns | 3.04±0.25 | 1.64±0.19 | <0.001*** |
| ACT score | 11.18±1.15 | 12.09±0.65 | ns | 12.25±1.08 | 17.42±1.11 | <0.001+ |
| SGRQ score | ||||||
| Symptoms | 57.41±5.97 | 53.85±6.74 | ns | 62.41±5.19 | 55.12±7.54 | ns |
| Activity | 82.43±2.86 | 81.17±2.95 | ns | 79.63±4.58 | 59.97±5.14 | <0.001§ |
| Impact | 61.65±4.88 | 54.40±4.28 | ns | 57.69±2.89 | 34.18±4.71 | <0.001ƒ |
| Total | 67.29±3.37 | 62.42±3.27 | ns | 65.12±3.02 | 45.47±4.42 | <0.001## |
| GERD-HRQL score | 8.00±2.93 | 10.38±2.12 | ns | 8.20±2.26 | 8.50±1.55 | ns |
Data are presented as mean±se unless otherwise stated. p-values were calculated by ANOVA. BMI: body mass index; ACQ: Asthma Control Questionnaire; ACT: Asthma Control Test; SGRQ: St George’s Respiratory Questionnaire; GERD-HRQL: Gastroesophageal Reflux Disease-Health-Related Quality-of-Life Scale; ns: nonsignificant. #: n=11; ¶: n=12. ***: p<0.001 between groups; +: p=0.024 between groups; §: p=0.005 between groups; ƒ: p=0.028 between groups; ##: p=0.011 between groups.